Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
New & experimental HIV treatments

Merck Opens Enrollment in New Phase 3 Clinical Trials with Investigational Once-Daily Islatravir in Combination with Doravirine for Treatment of HIV-1 Infection

Editor's pick
Merck press release
23 February 2023
Health problems in children & young people

Children's HIV Deaths in Africa Largely Preventable

Editor's pick
MedPage Today
23 February 2023
Injectable & long-acting HIV treatment

San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression

News
23 February 2023
Injectable & long-acting HIV treatment

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva (cabotegravir, rilpivirine) is as effective as daily oral Biktarvy (BIC/FTC/TAF) for the treatment of HIV-1

Editor's pick
ViiV press release
23 February 2023
Weight gain & lipodystrophy

Switching to injectable cabotegravir and rilpivirine rarely affects body weight

News
23 February 2023
Access to healthcare

Sharing anti-HIV medication is common in rural Uganda

News
23 February 2023
Changing treatment

Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment

News
23 February 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
Cardiovascular disease

HIV drug may be linked to increased risk of hypertension

Editor's pick
Medical Xpress
22 February 2023
HIV treatment for children & young people

ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD

Editor's pick
ViiV press release
22 February 2023
Cardiovascular disease

Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment

News
22 February 2023
Sexually transmitted infections prevention

Doxycycline PEP after sex appears ineffective for cisgender women

News
21 February 2023
Sexually transmitted infections prevention

No marked increase in gonorrhoea resistance in doxyPEP study

News
21 February 2023
Treatment outcomes & life expectancy

Trends in mortality in people living with HIV in an international cohort (RESPOND)

Editor's pick
NATAP
21 February 2023
Bad science & bogus treatments

‘Fraudulent and misleading’: why pricey herbal mix touted as a remedy for HIV falls flat

Editor's pick
Africa Check
9 February 2023
Contraception

New FSRH CEU guidance published: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception

Editor's pick
Faculty of Sexual and Reproductive Healthcare
7 February 2023
Menopause

Depression common in perimenopause, but HIV suppression rates remain steady, Swiss study reports

Editor's pick
The BodyPro
6 February 2023
Treatment for women

Not counted: clinical trials of new HIV treatments are failing women

News
3 February 2023
Bad science & bogus treatments

COVID-19 vaccines don't contain HIV

Editor's pick
Associated Press
31 January 2023
Access to healthcare

Darunavir/ritonavir (DRV/r) Advocacy!

Editor's pick
AfroCAB
27 January 2023
Adherence

Does Cannabis Use Impair HIV Treatment Adherence?

Editor's pick
POZ
26 January 2023
Drug interactions & pharmacokinetics

Protease-to-Integrase Switch Greatly Reduces HIV Drug-Drug Interaction Risk

Editor's pick
TheBodyPro
25 January 2023